Suchergebnisse

ZusammenfassungTrotz der zunehmenden Integration von Informationstechnologie (IT) im Bereich der klinischen Medizin ist eine zufrieden stellende Funktionalität in der onkologischen Datenerfassung noch nicht erreicht worden. Obwohl zahlreiche Klassifizierungssysteme nutzbar sind, Vereinheitlichungen zur Basisdokumentation durchgeführt wurden und ein Krebsregistergesetz verabschiedet wurde, ist eine zur Perinatalerhebung äquivalente Organisationsstruktur noch nicht vorhanden. Hier sind Lösungen nicht so sehr im Bereich der technischen Möglichkeiten, sondern im Bereich der Gesundheitspolitik einschließlich der Finanzierungskonzepte zu suchen. Für die Qualitätssicherung in der gynäkologischen Onkologie ist eine einheitliche, zentral auswertbare Datenerhebung unerlässlich. Diese ist ohne moderne Werkzeuge der Informationstechnologie und ohne einen einheitlichen Datensatz nicht realisierbar.

STUDY QUESTION: How are ART and IUI regulated, funded and registered in European countries? SUMMARY ANSWER: Of the 43 countries performing ART and IUI in Europe, and participating in the survey, specific legislation exists in only 39 countries, public funding (also available in the 39 countries) varies across and sometimes within countries and national registries are in place in 31 countries. WHAT IS KNOWN ALREADY: Some information devoted to particular aspects of accessibility to ART and IUI is available, but most is fragmentary or out-dated. Annual reports from the European IVF-Monitoring (EIM) Consortium for ESHRE clearly mirror different approaches in European countries regarding accessibility to and efficacy of those techniques. STUDY DESIGN, SIZE, DURATION: A survey was designed using the online SurveyMonkey tool consisting of 55 questions concerning three domains—legal, funding and registry. Answers refer to the countries' situation on 31 December 2018. PARTICIPANTS/MATERIALS, SETTINGS, METHODS: All members of EIM plus representatives of countries not yet members of the Consortium were invited to participate. Answers received were checked, and initial responders were asked to address unclear answers and to provide any additional information they considered important. Tables of individual countries resulting from the consolidated data were then sent to members of the Committee of National Representatives of ESHRE, asking for a second check. Conflicting information was clarified by direct contact. MAIN RESULTS AND THE ROLE OF CHANCE: Information was received from 43 out of the 44 European countries where ART and IUI are performed. Thirty-nine countries reported specific legislation on ART, and artificial insemination was considered an ART technique in 35 of them. Accessibility is limited to infertile couples in 11 of the 43 countries. A total of 30 countries offer treatments to single women and 18 to female couples. In five countries ART and IUI are permitted for treatment of all patient groups, being ...